SynCore Biotechnology Co (ROCO:4192) Days Sales Outstanding : 32.79 (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is SynCore Biotechnology Co Days Sales Outstanding?

SynCore Biotechnology Co's average Accounts Receivable for the three months ended in Dec. 2023 was NT$2.22 Mil. SynCore Biotechnology Co's Revenue for the three months ended in Dec. 2023 was NT$6.18 Mil. Hence, SynCore Biotechnology Co's Days Sales Outstanding for the three months ended in Dec. 2023 was 32.79.

The historical rank and industry rank for SynCore Biotechnology Co's Days Sales Outstanding or its related term are showing as below:

ROCO:4192' s Days Sales Outstanding Range Over the Past 10 Years
Min: 24.39 Med: 43.44 Max: 74.61
Current: 34.32

During the past 13 years, SynCore Biotechnology Co's highest Days Sales Outstanding was 74.61. The lowest was 24.39. And the median was 43.44.

ROCO:4192's Days Sales Outstanding is ranked better than
82.55% of 894 companies
in the Biotechnology industry
Industry Median: 71.92 vs ROCO:4192: 34.32

SynCore Biotechnology Co's Days Sales Outstanding increased from Dec. 2022 (28.60) to Dec. 2023 (32.79).

SynCore Biotechnology Co Days Sales Outstanding Historical Data

The historical data trend for SynCore Biotechnology Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SynCore Biotechnology Co Days Sales Outstanding Chart

SynCore Biotechnology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

32.44

30.07

73.19

38.52

37.09

SynCore Biotechnology Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															28.60	41.67	34.13	28.99	32.79

Competitive Comparison of SynCore Biotechnology Co's Days Sales Outstanding

For the Biotechnology subindustry, SynCore Biotechnology Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SynCore Biotechnology Co's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SynCore Biotechnology Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where SynCore Biotechnology Co's Days Sales Outstanding falls into.

SynCore Biotechnology Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

SynCore Biotechnology Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (1.669	+	2.436)	/	2 )	/	20.196	*	365
=	2.0525					/	20.196	*	365
=	37.09

SynCore Biotechnology Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (2.005	+	2.436)	/	2 )	/	6.179	*	365 / 4
=	2.2205					/	6.179	*	365 / 4
=	32.79

SynCore Biotechnology Co (ROCO:4192) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

SynCore Biotechnology Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of SynCore Biotechnology Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

SynCore Biotechnology Co (ROCO:4192) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SynCore Biotechnology Co Ltd (ROCO:4192) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.84 Zhongshan Road, Zhongshan Village, Dongshan Township, Yilan, TWN, 269

Website

https://www.syncorebio.com

SynCore Biotechnology Co Ltd is a biopharmaceutical company. Its pipeline products concentrate on the ophthalmology, oncology, and dermatology fields. The pipeline products of the company include SB01 and 02, SB03, SB04, and SB05. It is engaged in drug development and sale, food advisory, medicine inspection, biotechnology service and intellectual property. It operates in a single industry, the new drug development.

SynCore Biotechnology Co (ROCO:4192) Headlines

No Headlines